mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.03 |
0.3 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.3 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.3 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.3 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.3 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.3 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |